Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:10 AM
Ignite Modification Date:
2025-12-25 @ 4:10 AM
NCT ID:
NCT01286220
Eligibility Criteria:
Inclusion Criteria:
* 2-17 years of age at time of consent. A parent or legal guardian will be required to consent and authorize their enrollment in the study.
* Male or female of any ethnic background.
* English or Spanish speaking.
* A clinical diagnosis of atopic dermatitis for at least 6 months prior to enrollment.
* Must have moderate to severe atopic dermatitis as rated by the EASI score.
* Able to adhere to study visit schedule and other protocol requirements.
* Patients and/or family members must agree to not use any other prescription or over the counter medications other than the ones prescribed by the study protocol.
Exclusion Criteria:
* Clinical evidence of bacterial or viral superinfection on first visit.
* Have received phototherapy within 2 months prior to enrollment.
* Have received any systemic medication for atopic dermatitis or any that may affect evaluation of atopic dermatitis within 2 months prior to enrollment.
* Have a known hypersensitivity response, including anaphylaxis, to any of the topicals used for treatment (i.e. topical steroids, bleach)
* Participation in another clinical trial using an investigational agent or procedure.
* Pregnant or planning pregnancy or surgery during the participation in the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
2 Years
Maximum Age:
17 Years
Study:
NCT01286220
Study Brief:
Protocol Section:
NCT01286220